Our Future

Strategic Expansion into Sweden: A New Frontier for Innovation

With our blueprint proven in controlled pilot systems, Vita HydroKultur is scaling up – with precision, purpose, and permanence. We’ve chosen Sweden for our first commercial production facility: a European powerhouse of clean energy, biotech innovation, and progressive regulation.

This isn’t just a grow site. It’s a molecular horticulture facility purpose-built to produce high-value, plant-based proteins – reliably, repeatedly, and at commercial scale.

The Strategic Case for Sweden

Sweden wasn’t the only contender – but it was the clear winner. After evaluating multiple European locations, we chose Sweden because it delivers on every front that matters to molecular horticulture at scale: energy, regulation, innovation, infrastructure, and talent. Here’s what made the difference:

Political and Economic Stability
Clean, Cost-Effective Power
Progressive Regulatory Environment
Highly Educated, Multilingual Workforce
Cutting-Edge Research Ecosystem
Advanced Automation and Digital Infrastructure
First-Class Infrastructure and Logistics
Cool Climate Advantage
Strategic Gateway to EU Market

Political and Economic Stability

Sweden doesn’t just offer a safe haven for capital – it offers a launchpad. With a stable political climate, investor-friendly legal framework and an innovation-forward policy agenda, Sweden is one of the few countries where you can build something technically ambitious, globally relevant, and commercially secure – all at once.

Clean, Cost-Effective Power

Power is one of the biggest cost drivers in any Total Controlled Environment Horticulture (TCEH) system – and in our case, it could represent over 50% of total direct operating expenses.

This is exactly why Sweden stood out. With around 83% of its electricity generated from renewable sources, it’s not only one of the world’s greenest energy markets – it’s also one of the most reliable and cost-efficient in Europe.

But we went a step further. One of the decisive factors in selecting our specific location within Sweden was its proximity to a new 500 Mw hydroelectric facility scheduled for commissioning in 2027.

When we compared Sweden’s energy pricing to that of the UK, we found the UK to be up to five times more expensive per kilowatt-hour. That’s not just a sustainability win – it’s an economic one.

Progressive Regulatory Environment

Sweden takes a pragmatic, science-led approach to plant-based biotechnology. While aligned with EU frameworks, it has consistently led the charge in modernising how emerging technologies are regulated – especially in areas like transient expression systems, precision biology, and plant-based bio-manufacturing.

Crucially, Swedish regulators understand the distinction between open-environment interventions and highly controlled, precision-based platforms like ours. That clarity creates a path for innovation that is regulated without being strangled – a balance many countries still struggle to achieve. Contact has already been made with a representative of the Swedish Gene Technology Advisory Board, who has a PhD from Uppsala University, who is very excited about our project and would like to publish our activities on their website.

Highly Educated, Multilingual Workforce

A world-class facility is only as good as the people running it. In our case, that means talent at the intersection of biotech, precision horticulture, automation, and advanced analytics. Sweden gives us access to exactly that – and then some.

The country ranks consistently among the best in Europe for education, with universities that excel in life sciences, plant biology, data science, and engineering.

Sweden offers not just a highly educated workforce – but a scalable, stable, and internationally capable one, ready to power the next generation of bio-industrial innovation.

Cutting-Edge Research Ecosystem

Sweden isn’t just a country with clean power and stable governance – it’s a biotech powerhouse with a deep-rooted culture of scientific innovation. For us, that matters. We’re not building a basic grow-op. We’re building a biotech-integrated production platform at the frontier of molecular horticulture and recombinant protein expression – and that demands proximity to cutting-edge research, talent, and infrastructure.

Sweden doesn’t just support innovation – it accelerates it. And for a company like ours, that’s not just attractive. It’s essential.

Advanced Automation and Digital Infrastructure

Sweden consistently ranks as one of the most digitally advanced countries in the world. From widespread 5G infrastructure to AI research hubs and national-level investment in smart manufacturing, the country offers a uniquely fertile environment for building fully automated, data-driven bio-farming infrastructure.

Excellent Infrastructure & Logistics

Our facility’s success hinges on more than just advanced biotech – it requires a robust, reliable infrastructure to support every facet of our operations. Sweden offers an exceptional logistics ecosystem, particularly suited for the stringent demands of pharmaceutical grade bioproduction.

Sweden’s strategic position in Northern Europe provides seamless access to major markets.

By situating our facility in Sweden, we leverage a logistics and infrastructure ecosystem that is:

This strategic alignment positions us to meet the complex demands of modern bioproduction, ensuring our products reach global markets swiftly and safely.

Cool Climate Advantage

While it may sound counterintuitive to claim that Sweden’s chilly winters – with average January temperatures around -11°C – are an operational benefit, the reality is: they are.

Yes, we’re running a power-intensive indoor growing operation, and yes, climate control is central to the business model. But thanks to state-of-the-art insulation, passive thermal design, and a highly efficient energy system, the internal environment of the facility remains tightly controlled year-round – without battling massive seasonal energy swings.

But the real climatic upside? Biosecurity.

Even with multiple layers of contamination prevention – including airlocks, HEPA filters, gowning protocols, and positive-pressure clean zones – every biotech facility faces one unyielding truth: the outside world wants in. And with it come pests, fungi, airborne spores, and microbial hitchhikers.

Sweden’s cold climate acts as a natural microbial firewall.

Sweden’s colder climate acts like a quiet partner in our contamination control system. In warmer regions, growers fight a year-round battle with airborne spores, insects, fungal pathogens, and viral vectors – all of which raise the cost, complexity, and risk of molecular horticulture. In contrast, our Nordic site operates with a lower baseline threat level, which reduces:

By aligning our operations with the climate – rather than fighting it – we gain a quieter, cleaner, more controllable baseline. That’s not just good science; that’s smart business.

Strategic Gateway to the EU Market

By building in Sweden, we’re not just manufacturing in Europe – we’re operationalising at scale across Europe:

Faster commercialization of high-value, time-sensitive compounds like human-identical collagen, growth factors, and enzymes
Lower cost of compliance through single-market regulatory alignment
Tighter IP protection, ensuring our innovations stay ours
Real-time access to Europe’s biotech supply chain, logistics providers, and cold-chain distribution networks - with zero customs delays

And importantly, we gain access to generous EU-backed grant programmes and biotech R&D funding mechanisms – giving us financial firepower to stay ahead of the curve.

Sweden gives us the stability. The EU gives us the scale. Together, they give Vita HydroKultur a defensible, durable commercial launchpad into one of the world’s most lucrative, innovation-friendly markets.